Safety profile of oxcarbazepine: results from a prescription-event monitoring study

Epilepsia
Yvonne BuggySaad A W Shakir

Abstract

To monitor safety of oxcarbazepine, prescribed in primary care in England, using prescription-event monitoring (PEM). Postmarketing surveillance using observational cohort technique of PEM. Exposure data were obtained from dispensed British National Health Service prescriptions issued by general practitioners (GPs) March 2000-July 2003. Demographic, drug utilization, and clinical event data were collected from questionnaires posted to GPs at least 6 months after first prescription date for each patient. Incidence densities (IDs) (number of first reports per 1,000 patient-months of treatment) were calculated and differences for events reported in month 1 (ID(1)) and months 2-6 (ID(2-6)) (99% confidence intervals) were examined for changes in event rates. Follow-up and causality assessment of medically significant events were undertaken. The cohort comprised 2,243 patients [mean age 40.4 years; range 2-99 years; standard deviation (SD) 18.8; 46.3% (n = 1,038) male]. Most frequently reported primary indications were epilepsy, convulsion (n = 1,111; 49.5%, n = 209; 9.3%, respectively). GPs recorded 932 reasons for stopping medication in 698 (31.1%) patients; most frequent clinical reason "drowsiness/sedation" (n = 57; 2.5% of cohor...Continue Reading

References

Jan 1, 1992·Epilepsia·W A Hauser
Sep 1, 1987·Epilepsy Research·K J ReinikainenP J Riekkinen
Mar 1, 1993·Acta Neurologica Scandinavica·M L FriisJ Worm-Petersen
Sep 21, 1996·BMJ : British Medical Journal·B R McAvoy, E F Kaner
Oct 1, 1996·Clinical Pharmacokinetics·B RambeckP Wolf
Oct 1, 1996·Journal of Medical Ethics·A H Ahmed, K G Nicholson
Jan 1, 1997·Epilepsia·A Beydoun
Oct 26, 1999·Epilepsia·E S Tecoma
Dec 14, 1999·BMJ : British Medical Journal·L V WiltonR D Mann
Feb 22, 2000·Journal of the American Geriatrics Society·N M Punjabi, E Haponik
Jun 14, 2000·Seizure : the Journal of the British Epilepsy Association·S Shorvon
Jul 29, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I C Wong, S D Lhatoo
Jun 8, 2001·Clinical Therapeutics·M M Kalis, N A Huff
Jun 26, 2001·Seizure : the Journal of the British Epilepsy Association·P E Smith, UNKNOWN UK Oxcarbazepine Advisory Board
Mar 22, 2002·Deutsche medizinische Wochenschrift·I Walter-Sack, W E Haefeli
Jul 27, 2002·Adverse Drug Reactions and Toxicological Reviews·Subramoniam MadhusoodananJorge Sotelo
Dec 13, 2002·American Journal of Clinical Dermatology·Julia K Warnock, David W Morris
Jan 28, 2003·European Psychiatry : the Journal of the Association of European Psychiatrists·L Hosák, J Libiger
Mar 27, 2003·Pediatric Neurology·Gul SerdarogluBerrak Sarioglu
Apr 16, 2003·Journal of Pain and Symptom Management·Enrique Carrazana, Imao Mikoshiba
Apr 17, 2003·Epilepsy & Behavior : E&B·Ekrem KutluayAhmad Beydoun
May 10, 2003·Epilepsy & Behavior : E&B·Dieter Schmidt, Rajesh Sachdeo
Jun 12, 2004·The Journal of Pediatrics·Marilyn B EscobedoUNKNOWN Texas Neonatal Research Group
Sep 24, 2004·Epilepsy & Behavior : E&B·Dieter Schmidt, Christian E Elger
May 14, 2005·BMJ : British Medical Journal·Jennifer Prah Ruger, Derek Yach
Jun 1, 2005·The Journal of Family Planning and Reproductive Health Care·Melissa Dear
Jun 23, 2005·Current Medical Research and Opinion·Georgia Montouris
Aug 9, 2005·European Journal of Internal Medicine·Clio P Mavragani, Panayiotis G Vlachoyiannopoulos
Sep 6, 2005·European Journal of Pain : EJP·Sunil DograYing Wan
Jan 28, 2006·Seizure : the Journal of the British Epilepsy Association·G PaulettoUNKNOWN Triveneto Epilepsy Study Group
Dec 19, 2006·Pain Practice : the Official Journal of World Institute of Pain·Kulbir S WaliaYasin N Khan
Jan 4, 2007·Fortschritte der Neurologie-Psychiatrie·M FreidelH Vogel
Feb 17, 2007·European Journal of Health Law·Joseph Dute
May 9, 2007·Epilepsia·Silje AlvestadEylert Brodtkorb
Jun 15, 2007·Expert Review of Neurotherapeutics·Ekaterine PopovaEduard Vieta

❮ Previous
Next ❯

Citations

May 16, 2013·CNS Drugs·Athanasios Gaitatzis, Josemir W Sander
Nov 26, 2014·Journal of Pharmacology & Pharmacotherapeutics·Andreu Massot, Ana Gimenez-Arnau
Sep 13, 2015·Seizure : the Journal of the British Epilepsy Association·Annika SattlerTheodor W May
Jun 28, 2011·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Ali CansuPeyami Cinaz
Mar 1, 2011·General Hospital Psychiatry·Karthik DuraiswamyBangalore N Gangadhar
Nov 10, 2011·Pharmacoepidemiology and Drug Safety·Cecilie Johannessen Landmark, Svein I Johannessen
Jul 24, 2012·Seizure : the Journal of the British Epilepsy Association·Na HeWei-Ping Liao
Sep 20, 2011·The Journal of Allergy and Clinical Immunology·Tai-Ming KoShuen-Iu Hung
Oct 16, 2016·Expert Opinion on Drug Safety·Xi Lu, Xuefeng Wang
Aug 6, 2019·Frontiers in Medicine·Carla TorreAna Paula Martins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.